Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management

Pardanani, Animesh·2023·American Journal of Hematology

Cited by (131)

Items 101–131 of 131

  1. Case Report: Refractory systemic nmastocytosis with AML1::ETO+ acute myeloid leukemia driven by rare KIT mutation: remarkable therapeutic efficacy of avapritinib
    Song Xue, Man Chen, Hui-Peng Sun, Xingyu Cao · 2025 · Frontiers in Pediatrics
  2. Pre-diagnostic and non-advanced systemic mastocytosis without cutaneous involvement have an increased risk of anaphylaxis
    Andrea Sangalli, Valerio Pravettoni, Mariarita Sciumé, Dario Consonni, Silvio Sartorio, Nicola Montano, Federica Rivolta · 2025 · Frontiers in Allergy
  3. AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosis
    Kitsada Kangboonruang, Philippe Drabent, Fatlinda Maksut, Maxime Heintzé, Yves Lepelletier, Ludovic Lhermitte, Mélanie Féroul, Sébastien Letard, Caroline Kabore, Fabienne A. Brenet et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Understanding Hymenoptera Venom Allergy: Key Concepts and Clinical Approaches
    Gemma Vicens-Novell, Ana Puig Fuentes, Pilar Serrano Delgado, Berta Ruiz-León · 2025 · Current Treatment Options in Allergy
  5. From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disorders
    Laura Polivka, Olivier Hermine, Julien Rossignol · 2025 · Frontiers in Allergy
  6. Avapritinib Durably Improves Cutaneous Involvement of Indolent Systemic Mastocytosis in Patients Treated in the PIONEER Study
    Golder Francis, Frank Siebenhaar, Sigurd Broesby‐Olsen, Tracy I. George, Hanneke Oude Elberink, Stephen T. Oh, Huimin Lin, Ilda Bidollari, Janet Hong, Lauren M. Madigan et al. · 2025 · SKIN The Journal of Cutaneous Medicine
  7. Comparative Profiling of TCR Repertoires in Extranodal NK/T-Cell Lymphoma and Healthy Individuals Highlights Unique Clonal Expansions and Potential Diagnostic Biomarkers
    Tao Ma, Ping Wang, Linwei Ma, Weimin Liu, Xiupeng Ye, Minfang Liu, Qu Lin, Shuowen Jin · 2025 · Research Square
  8. Refractory cutaneous symptoms in systemic mastocytosis
    Laura K. Gleason, Safiyyah A. Bhatti, Molly Wallace, Jason B. Lee, Önder Alpdoğan, Neda Nikbakht · 2025 · JAAD Case Reports
  9. Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis
    Sezim Minbaeva, Stephen Keith Tyring · 2026 · Cureus
  10. Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation
    Danilo Faraci, Daniela Caravelli, Fabrizio Carnevale Schianca, Elena Zaniol, Fiorenza Enrico, Carlo Boffano, Carmelo Labate, Greta Sterpi, Alessandro Fornari, Valentina Fabiola Ilenia Sangiorgio et al. · 2026 · Frontiers in Oncology
  11. Aggressive systemic mastocytosis presenting as diffuse osteoblastic bone disease: a diagnostic pitfall mimicking metastatic cancer
    Ana Melício, Hélder Diogo Gonçalves, Mariana Dias, Sara Vasconcelos-Teixeira, João Madeira Lopes · 2026 · European Journal of Case Reports in Internal Medicine
  12. A Wolf in Sheep's clothing: Mastocytosis lurking under favorable risk AML
    Annapoorani Ramasamy, Anitha Veerachamy, Venkateswaran Vellaichamy Swaminathan, Kasiviswanathan Thiagarajan · 2026 · Pediatric Hematology Oncology Journal
  13. Anaphylaxis in the Elderly: A Neglected Population
    Anna Carbone, Maria Teresa Ventura, Elisa Boni, Rosalba Buquicchio, Antonio Francesco Maria Giuliano · 2026 · Current Treatment Options in Allergy
  14. Emerging Insights into Hereditary Alpha-Tryptasemia in the Context of Mast Cell Disorders: A Greek Case Series
    Fotios Koliofotis, Natalia Katrachoura, Niki Papapostolou, Styliani Τaka, Maria Martinou, Anthi Bouchla, Sotirios G. Papageorgiou, Michael P. Makris · 2026 · Journal of Personalized Medicine
  15. Treatment of systemic mastocytosis with associated hematologic neoplasm: midostaurin and beyond
    Sona Vardanyan, Håkon Reikvam · 2026 · Expert Review of Hematology
  16. Neoplastic mast cells from patients with mastocytosis express AXL : effects on proliferation, apoptosis, and resistance to tyrosine kinase inhibitors
    Kitsada Kangboonruang · 2024 · theses.fr (ABES)
  17. Clonal Mast Cell Disorders and Mutation Profile in Adults Initially Presenting with Mast Cell Activation (Anaphylaxis) versus Non-Anaphylactic Presentations: A Joint Allergy–Hematology Cohort
    Patchara Pornsuthirat, Weerapat Owattanapanich, Chamard Wongsa, Torpong Thongngarm, Mongkhon Sompornrattanaphan · 2026 · Journal of Asthma and Allergy
  18. Are biological therapies for the treatment of psoriasis safe in patients with systemic mastocytosis? A case report and review of the literature
    Giulia Rech, Davide Geat, Riccardo Balestri, Carla Lombardo · 2026 · Italian Journal of Dermatology and Venereology
  19. Smoldering Systemic Mastocytosis Without Detectable KIT Mutation: A Debilitating Course and Therapeutic Challenge
    Anna Homeniuk, Medina Esenbekova, Micheal Bishara, Layo Akinrinwoye, Leila Metellus, Joane Titus · 2026 · Cancer Nexus
  20. Systemic Mastocytosis Presenting as Non-cirrhotic Portal Hypertension With Upper Gastrointestinal Bleeding in a Young Female Patient: A Case Report
    Ashish Jangid, Prashant Pandey, Mohammad Shafat Siddiqui, O.P. Tiwari, Santosh K Pandey, Neeraj K Singh · 2026 · Cureus
  21. Unmasking Indolent Systemic Mastocytosis in Patients with Unexplained or Treatment-Refractory Osteoporosis: A Case Series with Diagnostic and Therapeutic Implications
    Lucia Jankovski, Rok Herman, Matej Rakuša, Peter Kopač, Mark Kačar, Matevž Škerget, Andrej Janež, Mojca Jensterle · 2026 · Biomolecules
  22. Unresponsive Systemic Mastocytosis in a Young AML With RUNX1::RUNX1T1 Fusion With Rare KIT c.1255_1257delGAC Mutation: A Clinical Deadlock
    K. V. Vinu Balraam, Amiya Ranjan Nayak, Jasmita Dass, Richa Chauhan, Ganesh Kumar Viswanathan, Mukul Aggarwal, Pradeep Kumar, Rishi Dhawan, Tulika Seth, Manoranjan Mahapatra · 2026 · Journal of Pediatric Hematology/Oncology
  23. Le rhumatologue et le mastocyte
    Marie Nansion · 2026 · Revue du Rhumatisme
  24. Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy — a case report
    Agnieszka Gawlewicz‐Mroczka, E. M. Gacek, Natalia Zamorska, Krzysztof Sładek · 2026 · Frontiers in Allergy
  25. Мастоцитоз – заболевание на границе аллергологии, дерматологии и гематологии
    E.Yu. Trushina Trushina, E.M. Kostina Kostina, Е.А. Орлова, A.A. Turovskaya Turovskaya · 2026 · Practical Allergology
  26. Objective Sleep Assessment in Systemic Mastocytosis: Polysomnographic Findings from a Single-Center Observational Study
    Hatice Serpil Akten, Şeyma Aykaç, Burhanettin Uludağ, Ceyda Tunakan Dalgıç, Reyhan Gümüşburun, Sinem İnan, Kasım Okan, Züleyha Galata, Eda Aslan, Ecem Ay et al. · 2026 · Journal of Clinical Medicine
  27. SuperRCA assay of KIT p.D816V mutation load reveals novel correlation to clinical phenotype
    Cecilia Karlström, Monika Klimkowska, Marie Engvall, Sofia Nordin, Ebba Westerberg, Sofia Papavasileiou, Joakim S. Dahlin, Johanna S. Ungerstedt · 2026 · Journal of Allergy and Clinical Immunology Global
  28. Diffuse osteosclerosis in a patient with systemic mastocytosis
    Huy Do, Balasubramanian Krishnamurthy, Vivian Grill, Christopher Leow, Hanh H. Nguyen · 2026 · JCEM Case Reports
  29. Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis
    Stijn Wigerinck, Peter Vandenberghe · 2026 · European Journal Of Haematology
  30. Myeloid neoplasm with PDGFRA rearrangement presenting in blast-phase with basophilia
    Anne-Cecilia van Marle, Evan Bowen · 2026 · Journal of Hematopathology
  31. Case Report: Coexistence of advanced systemic mastocytosis, chronic myelomonocytic Leukemia, and t(11;14)-positive plasma-cell neoplasm: a rare triple-clonal hematologic case
    Jun Yin, Jingyuan Luo, Linlin Huang, Ling Wang, Mingwei Zhong, Maoqin Li, Shihua Huang · 2026 · Frontiers in Oncology